Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $146,625 | 87 | 83.8% |
| Food and Beverage | $11,651 | 503 | 6.7% |
| Travel and Lodging | $9,648 | 74 | 5.5% |
| Consulting Fee | $6,883 | 3 | 3.9% |
| Education | $212.70 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $50,516 | 154 | $0 (2020) |
| Alkermes, Inc. | $37,304 | 73 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $30,665 | 98 | $0 (2024) |
| ITI, Inc. | $24,221 | 30 | $0 (2023) |
| Allergan, Inc. | $15,989 | 81 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $7,580 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $5,379 | 55 | $0 (2024) |
| Lundbeck LLC | $598.75 | 31 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $528.12 | 20 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $363.18 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,450 | 51 | E.R. Squibb & Sons, L.L.C. ($7,580) |
| 2023 | $8,962 | 41 | Alkermes, Inc. ($8,499) |
| 2022 | $25,530 | 57 | Alkermes, Inc. ($17,929) |
| 2021 | $12,835 | 23 | ITI, Inc. ($11,501) |
| 2020 | $12,202 | 38 | ITI, Inc. ($5,400) |
| 2019 | $47,945 | 187 | Otsuka America Pharmaceutical, Inc. ($24,043) |
| 2018 | $20,639 | 139 | Sunovion Pharmaceuticals Inc. ($15,492) |
| 2017 | $38,456 | 138 | Sunovion Pharmaceuticals Inc. ($16,430) |
All Payment Transactions
674 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $94.41 | General |
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $54.08 | General |
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $40.33 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,980.00 | General |
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $38.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Neurology | ||||||
| 12/02/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $448.76 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $249.66 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $55.49 | General |
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Neurology | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $7.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 104 | 325 | $59,721 | $21,625 |
| 2022 | 3 | 108 | 349 | $66,072 | $24,266 |
| 2021 | 4 | 192 | 409 | $70,773 | $29,361 |
| 2020 | 3 | 191 | 427 | $63,475 | $21,657 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 259 | $53,095 | $19,077 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 38 | $5,282 | $2,063 | 39.1% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 19 | 28 | $1,344 | $484.36 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 284 | $58,220 | $21,163 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 52 | $7,228 | $2,821 | 39.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 11 | 13 | $624.00 | $282.07 | 45.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 236 | $48,380 | $21,712 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 139 | $19,321 | $6,990 | 36.2% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 13 | 19 | $912.00 | $389.16 | 42.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 15 | $2,160 | $270.47 | 12.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 111 | 298 | $41,422 | $14,143 | 34.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 37 | 72 | $10,368 | $3,999 | 38.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 57 | $11,685 | $3,516 | 30.1% |
About Dr. Joseph Harrison, MD
Dr. Joseph Harrison, MD is a Psychiatry healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104842624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Harrison, MD has received a total of $175,018 in payments from pharmaceutical and medical device companies, with $8,450 received in 2024. These payments were reported across 674 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($146,625).
As a Medicare-enrolled provider, Harrison has provided services to 595 Medicare beneficiaries, totaling 1,510 services with total Medicare billing of $96,909. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Owensboro, KY
- Active Since 07/15/2006
- Last Updated 10/17/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1104842624
Products in Payments
- LATUDA (Drug) $50,422
- LYBALVI (Drug) $26,812
- REXULTI (Drug) $26,349
- CAPLYTA (Drug) $24,267
- VRAYLAR (Drug) $16,122
- Aristada 441 mg (Drug) $10,018
- ABILIFY MAINTENA (Drug) $4,683
- INVEGA SUSTENNA (Drug) $3,041
- INVEGA TRINZA (Drug) $2,107
- ARISTADA (Drug) $473.79
- INGREZZA (Drug) $352.77
- Fanapt (Drug) $298.22
- AUSTEDO (Drug) $280.49
- SPRAVATO (Drug) $230.09
- TRINTELLIX (Drug) $135.24
- Azstarys (Drug) $128.80
- JORNAY PM (Drug) $89.50
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $80.17
- AZSTARYS (Drug) $79.59
- Adzenys XR-ODT (Drug) $72.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Owensboro
Jin Amon, M.d, M.D
Psychiatry — Payments: $3,734
Dr. Timothy Burke, M.d, M.D
Psychiatry — Payments: $1,916
Dr. Rhine Hejran, M.d, M.D
Psychiatry — Payments: $1,181
David Harmon, D.o, D.O
Psychiatry — Payments: $1,094
Dr. Debra Bunger, Md, MD
Psychiatry — Payments: $723.35
Erik Rotterman, Md, MD
Psychiatry — Payments: $168.71